Procaps Group, S.A. (PROCW)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 199.47 Million USD | 20.72% |
| 2021 | 165.24 Million USD | 28.84% |
| 2020 | 128.26 Million USD | -11.59% |
| 2019 | 145.06 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q1 | 42.78 Million USD | -14.5% |
| 2023 Q3 | 55.35 Million USD | 19.97% |
| 2023 Q2 | 46.13 Million USD | 7.83% |
| 2022 FY | 199.47 Million USD | 20.72% |
| 2022 Q4 | 50.04 Million USD | -0.34% |
| 2022 Q3 | 50.21 Million USD | -7.88% |
| 2022 Q2 | 54.51 Million USD | 21.91% |
| 2022 Q1 | 44.71 Million USD | 13.53% |
| 2021 Q1 | 40.05 Million USD | 29.01% |
| 2021 FY | 165.24 Million USD | 28.84% |
| 2021 Q2 | 41.95 Million USD | 4.72% |
| 2021 Q4 | 39.38 Million USD | -10.19% |
| 2021 Q3 | 43.85 Million USD | 4.53% |
| 2020 Q4 | 31.05 Million USD | -7.6% |
| 2020 Q3 | 33.6 Million USD | 11.29% |
| 2020 Q1 | 33.41 Million USD | 0.0% |
| 2020 FY | 128.26 Million USD | -11.59% |
| 2020 Q2 | 30.19 Million USD | -9.62% |
| 2019 FY | 145.06 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bright Green Corporation | 8.25 Million USD | -2317.062% |
| Alpha Teknova, Inc. | 45.85 Million USD | -334.979% |
| ANI Pharmaceuticals, Inc. | 195.98 Million USD | -1.783% |
| Aquestive Therapeutics, Inc. | 44.85 Million USD | -344.725% |
| Collegium Pharmaceutical, Inc. | 159.2 Million USD | -25.293% |
| Cosmos Health Inc. | 26.18 Million USD | -661.921% |
| Journey Medical Corporation | 54.59 Million USD | -265.383% |
| Embecta Corp. | 528.4 Million USD | 62.249% |
| Esperion Therapeutics, Inc. | 271.89 Million USD | 26.635% |
| Dynavax Technologies Corporation | 219.14 Million USD | 8.975% |
| Intra-Cellular Therapies, Inc. | 590 Million USD | 66.191% |
| Pacira BioSciences, Inc. | 326.37 Million USD | 38.881% |
| PainReform Ltd. | 9.58 Million USD | -1981.354% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -1419.886% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -1419.886% |
| SCYNEXIS, Inc. | 51.84 Million USD | -284.734% |
| Safety Shot Inc | 12.1 Million USD | -1547.251% |
| China SXT Pharmaceuticals, Inc. | 3.06 Million USD | -6399.341% |
| Theratechnologies Inc. | 72.75 Million USD | -174.173% |
| Harrow Health, Inc. | 89.97 Million USD | -121.708% |
| Sonoma Pharmaceuticals, Inc. | 9.44 Million USD | -2011.762% |
| Biofrontera Inc. | 39.95 Million USD | -399.204% |
| DURECT Corporation | 43.71 Million USD | -356.312% |
| Supernus Pharmaceuticals, Inc. | 529.01 Million USD | 62.292% |
| Cronos Group Inc. | 96.7 Million USD | -106.265% |
| OptiNose, Inc. | 85.1 Million USD | -134.398% |
| Ironwood Pharmaceuticals, Inc. | 232.12 Million USD | 14.064% |
| Kala Pharmaceuticals, Inc. | 39.15 Million USD | -409.481% |
| RedHill Biopharma Ltd. | -9.56 Million USD | 2186.361% |
| Organogenesis Holdings Inc. | 314.13 Million USD | 36.499% |
| Guardion Health Sciences, Inc. | 9.73 Million USD | -1949.948% |
| Cumberland Pharmaceuticals Inc. | 43.04 Million USD | -363.463% |
| Radius Health, Inc. | 265.92 Million USD | 24.989% |
| Universe Pharmaceuticals INC | 13.84 Million USD | -1341.109% |
| ProPhase Labs, Inc. | 37.85 Million USD | -426.992% |
| Phibro Animal Health Corporation | 260.29 Million USD | 23.366% |
| Procaps Group S.A. | 187.24 Million USD | -6.533% |
| Alvotech | 285.43 Million USD | 30.115% |
| TherapeuticsMD, Inc. | 9.82 Million USD | -1930.3% |
| Viatris Inc. | 5.96 Billion USD | 96.656% |
| Rockwell Medical, Inc. | 15.37 Million USD | -1197.496% |
| Aytu BioPharma, Inc. | 59.84 Million USD | -233.351% |
| SIGA Technologies, Inc. | 22.04 Million USD | -804.944% |
| Tilray Brands, Inc. | 251.35 Million USD | 20.64% |
| Lifecore Biomedical, Inc. | 49.03 Million USD | -306.78% |
| Shineco, Inc. | 17.94 Million USD | -1011.414% |
| PetIQ, Inc. | 192.72 Million USD | -3.503% |
| Regencell Bioscience Holdings Limited | 3.99 Million USD | -4897.998% |
| Incannex Healthcare Limited | 30.05 Million USD | -563.751% |
| Neurocrine Biosciences, Inc. | 1.59 Billion USD | 87.505% |
| Alimera Sciences, Inc. | 62.64 Million USD | -218.445% |
| Silver Spike Investment Corp. | 762.49 Thousand USD | -26061.193% |
| Assertio Holdings, Inc. | 368.58 Million USD | 45.88% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.88 Million USD | -3289.255% |
| Petros Pharmaceuticals, Inc. | 17.8 Million USD | -1020.12% |
| Clever Leaves Holdings Inc. | 21.16 Million USD | -842.307% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -847.99% |
| Avadel Pharmaceuticals plc | 164.96 Million USD | -20.92% |
| Hempacco Co., Inc. | 7.59 Million USD | -2525.924% |
| Talphera, Inc. | 11.99 Million USD | -1563.14% |
| Alvotech | 285.43 Million USD | 30.115% |
| Eagle Pharmaceuticals, Inc. | 140.71 Million USD | -41.761% |
| Lantheus Holdings, Inc. | 344.9 Million USD | 42.164% |
| Currenc Group, Inc. | 24 Million USD | -731.082% |
| Kamada Ltd. | 45.42 Million USD | -339.125% |
| Indivior PLC | 911 Million USD | 78.104% |
| Evoke Pharma, Inc. | 12.4 Million USD | -1507.436% |
| Flora Growth Corp. | 10.57 Million USD | -1785.594% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -847.99% |
| Evolus, Inc. | 189.75 Million USD | -5.121% |
| HUTCHMED (China) Limited | 436.23 Million USD | 54.273% |
| Amphastar Pharmaceuticals, Inc. | 154.13 Million USD | -29.418% |
| Akanda Corp. | 3.48 Million USD | -5626.325% |